PL3071194T3 - Leczenie farmakologiczne zaburzeń obsesyjno-kompulsywnych z użyciem styrypentolu lub podobnego związku - Google Patents
Leczenie farmakologiczne zaburzeń obsesyjno-kompulsywnych z użyciem styrypentolu lub podobnego związkuInfo
- Publication number
- PL3071194T3 PL3071194T3 PL14820758.2T PL14820758T PL3071194T3 PL 3071194 T3 PL3071194 T3 PL 3071194T3 PL 14820758 T PL14820758 T PL 14820758T PL 3071194 T3 PL3071194 T3 PL 3071194T3
- Authority
- PL
- Poland
- Prior art keywords
- stiripentol
- obsessive
- compulsive disorder
- similar compound
- pharmacological treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13306586.2A EP2875810A1 (en) | 2013-11-20 | 2013-11-20 | Pharmacological treatment of obsessive-compulsive disorder using Stiripentol or a similar compound |
| PCT/EP2014/075213 WO2015075155A1 (en) | 2013-11-20 | 2014-11-20 | Pharmacological treatment of obsessive-compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3071194T3 true PL3071194T3 (pl) | 2022-12-05 |
Family
ID=49674249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14820758.2T PL3071194T3 (pl) | 2013-11-20 | 2014-11-20 | Leczenie farmakologiczne zaburzeń obsesyjno-kompulsywnych z użyciem styrypentolu lub podobnego związku |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10696647B2 (pl) |
| EP (2) | EP2875810A1 (pl) |
| JP (1) | JP6542788B2 (pl) |
| CA (1) | CA2931162C (pl) |
| DK (1) | DK3071194T3 (pl) |
| ES (1) | ES2928895T3 (pl) |
| HU (1) | HUE060188T2 (pl) |
| PL (1) | PL3071194T3 (pl) |
| PT (1) | PT3071194T (pl) |
| WO (1) | WO2015075155A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7179739B2 (ja) * | 2017-02-10 | 2022-11-29 | アサリナ ファーマ アーベー | 医学的治療における使用のための３－β－ヒドロキシ－５－α－プレグナン－２０－オン |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795893A (fr) | 1972-02-28 | 1973-06-18 | Unicler | Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique |
| FR2253503A2 (en) * | 1973-12-10 | 1975-07-04 | Unicler | Ethylenic piperonal alcohols and ketones - anxiolytics, antidepressants, hypnotics and tranquillisers |
| FR2253505A2 (en) * | 1973-12-10 | 1975-07-04 | Unicler | Alpha ethylenic alcohol and ketone derivs of pinacoline - modifiers of hexobarbital narcosis and anticonvulsants |
| US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
| WO2001064223A1 (en) * | 2000-02-29 | 2001-09-07 | Merck Frosst Canada & Co. | Method for treating or preventing depression |
| US20100184806A1 (en) * | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| AU2007299920A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | PPAR Mediated Modulation of Neurogenesis |
| US20110207718A1 (en) * | 2008-08-06 | 2011-08-25 | Gosforth Centre (Holdings) Pty Ltd. | Compositions and methods for treating psychiatric disorders |
| SI2201950T1 (sl) * | 2008-12-08 | 2017-05-31 | Biocodex | Spojine in metode za zdravljenje motenj avtističnega spektra |
-
2013
- 2013-11-20 EP EP13306586.2A patent/EP2875810A1/en not_active Withdrawn
-
2014
- 2014-11-20 JP JP2016554907A patent/JP6542788B2/ja active Active
- 2014-11-20 CA CA2931162A patent/CA2931162C/en active Active
- 2014-11-20 PT PT148207582T patent/PT3071194T/pt unknown
- 2014-11-20 ES ES14820758T patent/ES2928895T3/es active Active
- 2014-11-20 HU HUE14820758A patent/HUE060188T2/hu unknown
- 2014-11-20 WO PCT/EP2014/075213 patent/WO2015075155A1/en active Application Filing
- 2014-11-20 EP EP14820758.2A patent/EP3071194B1/en active Active
- 2014-11-20 DK DK14820758.2T patent/DK3071194T3/da active
- 2014-11-20 US US15/038,011 patent/US10696647B2/en active Active
- 2014-11-20 PL PL14820758.2T patent/PL3071194T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3071194B1 (en) | 2022-08-03 |
| EP2875810A1 (en) | 2015-05-27 |
| EP3071194A1 (en) | 2016-09-28 |
| US10696647B2 (en) | 2020-06-30 |
| CA2931162A1 (en) | 2015-05-28 |
| US20160289205A1 (en) | 2016-10-06 |
| CA2931162C (en) | 2022-07-19 |
| ES2928895T3 (es) | 2022-11-23 |
| WO2015075155A1 (en) | 2015-05-28 |
| DK3071194T3 (da) | 2022-10-24 |
| JP2016537435A (ja) | 2016-12-01 |
| PT3071194T (pt) | 2022-11-03 |
| HUE060188T2 (hu) | 2023-02-28 |
| JP6542788B2 (ja) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249518B (en) | A compound that inhibits trk | |
| HK1220741A1 (zh) | 納米層壓塗層 | |
| GB201321146D0 (en) | Quinazoline compounds | |
| GB201302368D0 (en) | Compound | |
| GB2534272B (en) | Rotationally-independent wellbore ranging | |
| HK1219100A1 (zh) | 吡啶基吡唑並喹啉化合物 | |
| PL2970713T3 (pl) | Powłoki miękkie w dotyku | |
| GB2532628B (en) | Lock | |
| EP2947066A4 (en) | PHENOXYALKYLAMINVERBINDUNG | |
| EP2986595A4 (en) | epoxidation | |
| GB2510931B (en) | Chod rig | |
| PL3071194T3 (pl) | Leczenie farmakologiczne zaburzeń obsesyjno-kompulsywnych z użyciem styrypentolu lub podobnego związku | |
| GB201307331D0 (en) | Compound | |
| GB201408643D0 (en) | Compound | |
| GB2517181B (en) | Lock | |
| GB201317534D0 (en) | Lock | |
| ZA201306669B (en) | Lock out member | |
| GB201322438D0 (en) | Compound | |
| GB201309984D0 (en) | Lock | |
| IL230265A0 (en) | Improved lock | |
| GB201306106D0 (en) | anti-barricade lock | |
| GB201315772D0 (en) | Compound | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound |